Viewing Study NCT05721950


Ignite Creation Date: 2025-12-24 @ 5:03 PM
Ignite Modification Date: 2025-12-27 @ 2:12 AM
Study NCT ID: NCT05721950
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-03-27
First Post: 2023-02-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Learn About Brigatinib Treatment Information Available in Chinese Participants With Non-Small-cell Lung Cancer (NSCLC)
Sponsor: Takeda
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module